Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr196.00 SEK
Change Today -2.00 / -1.01%
Volume 31.8K
NOLAB On Other Exchanges
Symbol
Exchange
OTC US
Stuttgart
Stockholm
As of 11:30 AM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

nolato ab-b shs (NOLAB) Snapshot

Open
kr198.00
Previous Close
kr198.00
Day High
kr201.50
Day Low
kr196.00
52 Week High
02/23/15 - kr212.50
52 Week Low
10/16/14 - kr135.00
Market Cap
5.2B
Average Volume 10 Days
31.0K
EPS TTM
kr13.84
Shares Outstanding
23.5M
EX-Date
04/30/15
P/E TM
14.2x
Dividend
kr8.50
Dividend Yield
4.08%
Current Stock Chart for NOLATO AB-B SHS (NOLAB)

Related News

No related news articles were found.

nolato ab-b shs (NOLAB) Related Businessweek News

No Related Businessweek News Found

nolato ab-b shs (NOLAB) Details

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomers polymer material products for medical technology, pharmaceuticals, telecom, automotive, and other various industrial sectors worldwide. The company operates through three segments: Nolato Medical, Nolato Telecom, and Nolato Industrial. The Nolato Medical segment offers inhalers and check valves for asthma, insulin pens and infusion sets for diabetes, seals and earpieces for hearing aids, seals for pacemakers and cardiac anchors for heart rhythm treatment, seals and connectors for dialysis, urinary catheters and urodomes for urology, catheter balloons and blood purification equipment for surgery, and allergy and pregnancy tests for analysis, as well as plastic packaging products for pharmaceutical and dietary supplement industries. The Nolato Telecom segment provides various components and subsystems in the mobile phones, such as injection-molded, painted, and decorated components; and adhesive components with mechanical and/or cosmetic functions comprising logos, speaker grilles, and three-dimensional design elements, as well as process and material solutions for shielding electronics against electromagnetic interference. The Nolato Industrial segment offers gaskets for engines and exhaust systems, interior fittings, motor components, battery boxes, etc. for the automotive industry; components for microwave ovens and chainsaws, flush buttons and flushing mechanisms for toilets, and transportation crates for the clothing industry; and ball retainers and storage seals for ball bearings, office chair components, conveyor belts, insert blocks to seal cables, and pipe transits. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was founded in 1938 and is based in Torekov, Sweden.

8,020 Employees
Last Reported Date: 02/5/15
Founded in 1938

nolato ab-b shs (NOLAB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nolato ab-b shs (NOLAB) Key Developments

Nolato AB (Publ) Announces Dividend Proposals for the Year 2014

The Board of Directors of Nolato AB (publ) proposed an increase in dividend to SEK 8.50 (8.00) per share for the Year 2014.

Nolato AB (Publ) Announces Consolidated and Parent Financial Results for the Fourth Quarter and Full Year Ended December 31, 2014

Nolato AB (publ) announced consolidated and parent financial results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported on group basis net sales of SEK 1,242 million against SEK 985 million a year ago. Operating profit was SEK 160 million against SEK 87 million a year ago. Profit after financial income and expense was SEK 162 million against SEK 88 million a year ago. Profit after tax was SEK 133 million or SEK 5.06 per diluted share against SEK 77 million or SEK 2.93 per diluted share a year ago. Cash flow from operating activities was SEK 138 million against SEK 223 million a year ago. Adjusted earnings was SEK 136 million or SEK 5.17 per share against SEK 80 million or SEK 3.04 per share a year ago. Return on shareholders' equity was 25.0% against 24.9% a year ago. Cash flow per share, excl. acq. and disposals was SEK 3.42 against SEK 6.27 a year ago. EBITDA was SEK 206 million against SEK 128 million a year ago. For the year, the company reported on group basis net sales of SEK 4,234 million against SEK 4,522 million a year ago. Operating profit was SEK 454 million against SEK 411 million a year ago. Profit after financial income and expense was SEK 462 million against SEK 403 million a year ago. Profit after tax was SEK 364 million or SEK 13.84 per diluted share against SEK 314 million or SEK 11.94 per diluted share a year ago. Cash flow from operating activities was SEK 330 million against SEK 512 million a year ago. Adjusted earnings was SEK 376 million or SEK 14.29 per share against SEK 326 million or SEK 12.39 per share a year ago. Return on shareholders' equity was 25.0% against 24.9% a year ago. Cash flow per share, excl. acq. and disposals was SEK 4.83 against SEK 13.76 a year ago. EBITDA was SEK 619 million against SEK 568 million a year ago. For the quarter, the company reported on parent basis net sales of SEK 7 million against SEK 3 million a year ago. Operating loss of SEK 14 million against SEK 14 million a year ago. Profit after financial income and expense was SEK 49 million against SEK 79 million a year ago. Profit before tax was SEK 273 million against SEK 198 million a year ago. For the year, the company reported on parent basis net sales of SEK 29 million against SEK 23 million a year ago. Operating loss of SEK 36 million against SEK 31 million a year ago. Profit after financial income and expense was SEK 85 million against SEK 85 million a year ago. Profit before tax was SEK 310 million against SEK 194 million a year ago.

Nolato Medical Reports Earnings Results for the Fourth Quarter and Full Year 2014

Nolato Medical reported earnings results for the fourth quarter and full year 2014. For the quarter, sales were SEK 334 million compared to SEK 313 million a year ago; adjusted for currency, sales increased 1%. EBITA rose to SEK 43 million compared to SEK 39 million a year ago. For the year, sales rose by 5% to SEK 1,333 million compared to SEK 1,274 million a year ago. EBITA was SEK 176 million compared to SEK 165 million a year ago. EBIT was SEK 163 million compared to SEK 152 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOLAB:SS kr196.00 SEK -2.00

NOLAB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NOLAB.
View Industry Companies
 

Industry Analysis

NOLAB

Industry Average

Valuation NOLAB Industry Range
Price/Earnings 13.3x
Price/Sales 1.1x
Price/Book 3.1x
Price/Cash Flow 11.9x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOLATO AB-B SHS, please visit www.nolato.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.